Titre : Anticorps

Anticorps : Questions médicales fréquentes

Termes MeSH sélectionnés :

Refractive Errors

Questions fréquentes et termes MeSH associés

Diagnostic 5

#1

Comment détecte-t-on les anticorps dans le sang ?

On utilise des tests sérologiques comme l'ELISA pour mesurer les anticorps.
Anticorps Tests sérologiques
#2

Quels tests sont utilisés pour les anticorps spécifiques ?

Des tests comme l'immunofluorescence ou les tests d'agglutination sont utilisés.
Anticorps Immunofluorescence
#3

Les anticorps peuvent-ils indiquer une infection ?

Oui, la présence d'anticorps spécifiques peut indiquer une infection antérieure.
Anticorps Infection
#4

Qu'est-ce qu'un titre d'anticorps ?

C'est une mesure de la concentration d'anticorps dans le sang, indiquant l'immunité.
Anticorps Immunité
#5

Les anticorps peuvent-ils être détectés chez les nouveau-nés ?

Oui, les anticorps maternels peuvent être détectés chez les nouveau-nés.
Anticorps Nouveau-né

Symptômes 5

#1

Quels symptômes indiquent une réponse immunitaire ?

Fièvre, fatigue, et inflammation peuvent indiquer une réponse immunitaire active.
Réponse immunitaire Symptômes
#2

Les anticorps causent-ils des symptômes ?

Non, ce sont les maladies ou infections que les anticorps combattent qui causent des symptômes.
Anticorps Maladies infectieuses
#3

Comment les anticorps affectent-ils les allergies ?

Les anticorps IgE sont impliqués dans les réactions allergiques, provoquant des symptômes.
Anticorps Allergies
#4

Les anticorps peuvent-ils causer des maladies auto-immunes ?

Oui, des anticorps peuvent attaquer les tissus sains, entraînant des maladies auto-immunes.
Anticorps Maladies auto-immunes
#5

Quels anticorps sont liés aux infections virales ?

Les anticorps IgM et IgG sont souvent associés aux infections virales.
Anticorps Infections virales

Prévention 5

#1

Comment les vaccins stimulent-ils la production d'anticorps ?

Les vaccins introduisent des antigènes, entraînant la production d'anticorps spécifiques.
Vaccins Anticorps
#2

Les anticorps peuvent-ils être transférés par le lait maternel ?

Oui, les anticorps maternels sont transférés au bébé par le lait maternel, offrant une protection.
Anticorps Lait maternel
#3

Comment maintenir un système immunitaire fort ?

Une alimentation équilibrée, l'exercice et le sommeil aident à maintenir un système immunitaire fort.
Système immunitaire Prévention
#4

Les anticorps peuvent-ils être utilisés pour prévenir le COVID-19 ?

Des traitements par anticorps monoclonaux sont utilisés pour prévenir les formes graves du COVID-19.
COVID-19 Anticorps monoclonaux
#5

Les anticorps sont-ils efficaces contre toutes les infections ?

Non, leur efficacité dépend du type d'infection et de la réponse immunitaire individuelle.
Anticorps Infections

Traitements 5

#1

Comment les anticorps sont-ils utilisés en thérapie ?

Des anticorps monoclonaux sont utilisés pour traiter diverses maladies, y compris le cancer.
Anticorps monoclonaux Thérapie
#2

Les anticorps peuvent-ils être administrés par injection ?

Oui, les anticorps peuvent être administrés par injection pour traiter certaines maladies.
Anticorps Injection
#3

Qu'est-ce que l'immunothérapie par anticorps ?

C'est un traitement qui utilise des anticorps pour renforcer la réponse immunitaire contre le cancer.
Immunothérapie Anticorps
#4

Les anticorps peuvent-ils être utilisés pour prévenir des maladies ?

Oui, des anticorps spécifiques peuvent être administrés pour prévenir certaines infections.
Anticorps Prévention des maladies
#5

Quels sont les effets secondaires des traitements par anticorps ?

Les effets secondaires peuvent inclure des réactions allergiques et des infections.
Anticorps Effets secondaires

Complications 5

#1

Quels sont les risques d'une surproduction d'anticorps ?

Une surproduction peut entraîner des maladies auto-immunes ou des allergies graves.
Anticorps Maladies auto-immunes
#2

Les anticorps peuvent-ils causer des réactions allergiques ?

Oui, certains anticorps peuvent provoquer des réactions allergiques en réponse à des allergènes.
Anticorps Réactions allergiques
#3

Quelles complications peuvent survenir avec des anticorps monoclonaux ?

Des infections, des réactions allergiques et des effets secondaires peuvent survenir.
Anticorps monoclonaux Complications
#4

Les anticorps peuvent-ils interférer avec d'autres traitements ?

Oui, certains anticorps peuvent interagir avec d'autres médicaments, affectant leur efficacité.
Anticorps Interactions médicamenteuses
#5

Quelles sont les complications des maladies auto-immunes ?

Les complications incluent des dommages aux organes, des infections et une qualité de vie réduite.
Maladies auto-immunes Complications

Facteurs de risque 5

#1

Quels facteurs augmentent le risque de maladies auto-immunes ?

Des facteurs génétiques, environnementaux et hormonaux peuvent augmenter ce risque.
Facteurs de risque Maladies auto-immunes
#2

Le stress influence-t-il la production d'anticorps ?

Oui, le stress chronique peut affecter la réponse immunitaire et la production d'anticorps.
Stress Anticorps
#3

L'âge influence-t-il la réponse des anticorps ?

Oui, la réponse des anticorps peut diminuer avec l'âge, rendant les personnes âgées plus vulnérables.
Âge Anticorps
#4

Les infections antérieures affectent-elles la production d'anticorps ?

Oui, des infections antérieures peuvent influencer la mémoire immunitaire et la production d'anticorps.
Infections Anticorps
#5

Les habitudes alimentaires influencent-elles les anticorps ?

Oui, une alimentation riche en nutriments peut soutenir la production d'anticorps et la santé immunitaire.
Habitudes alimentaires Anticorps
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Anticorps : Questions médicales les plus fréquentes", "headline": "Anticorps : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Anticorps : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-04-30", "dateModified": "2025-04-25", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Anticorps" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Immunoglobulines", "url": "https://questionsmedicales.fr/mesh/D007136", "about": { "@type": "MedicalCondition", "name": "Immunoglobulines", "code": { "@type": "MedicalCode", "code": "D007136", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.377.715.548" } } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Anticorps anti-idiotypiques", "alternateName": "Antibodies, Anti-Idiotypic", "url": "https://questionsmedicales.fr/mesh/D000888", "about": { "@type": "MedicalCondition", "name": "Anticorps anti-idiotypiques", "code": { "@type": "MedicalCode", "code": "D000888", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.377.715.548.114.071" } } }, { "@type": "MedicalWebPage", "name": "Anticorps anti-archéens", "alternateName": "Antibodies, Archaeal", "url": "https://questionsmedicales.fr/mesh/D019844", "about": { "@type": "MedicalCondition", "name": "Anticorps anti-archéens", "code": { "@type": "MedicalCode", "code": "D019844", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.377.715.548.114.107" } } }, { "@type": "MedicalWebPage", "name": "Anticorps antibactériens", "alternateName": "Antibodies, Bacterial", "url": "https://questionsmedicales.fr/mesh/D000907", "about": { "@type": "MedicalCondition", "name": "Anticorps antibactériens", "code": { "@type": "MedicalCode", "code": "D000907", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.377.715.548.114.125" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Antistreptolysine", "alternateName": "Antistreptolysin", "url": "https://questionsmedicales.fr/mesh/D000989", "about": { "@type": "MedicalCondition", "name": "Antistreptolysine", "code": { "@type": "MedicalCode", "code": "D000989", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.377.715.548.114.125.288" } } } ] }, { "@type": "MedicalWebPage", "name": "Anticorps bispécifiques", "alternateName": "Antibodies, Bispecific", "url": "https://questionsmedicales.fr/mesh/D018033", "about": { "@type": "MedicalCondition", "name": "Anticorps bispécifiques", "code": { "@type": "MedicalCode", "code": "D018033", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.377.715.548.114.134" } } }, { "@type": "MedicalWebPage", "name": "Anticorps bloquants", "alternateName": "Antibodies, Blocking", "url": "https://questionsmedicales.fr/mesh/D019138", "about": { "@type": "MedicalCondition", "name": "Anticorps bloquants", "code": { "@type": "MedicalCode", "code": "D019138", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.377.715.548.114.143" } } }, { "@type": "MedicalWebPage", "name": "Anticorps catalytiques", "alternateName": "Antibodies, Catalytic", "url": "https://questionsmedicales.fr/mesh/D017151", "about": { "@type": "MedicalCondition", "name": "Anticorps catalytiques", "code": { "@type": "MedicalCode", "code": "D017151", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.377.715.548.114.167" } } }, { "@type": "MedicalWebPage", "name": "Anticorps antifongiques", "alternateName": "Antibodies, Fungal", "url": "https://questionsmedicales.fr/mesh/D000908", "about": { "@type": "MedicalCondition", "name": "Anticorps antifongiques", "code": { "@type": "MedicalCode", "code": "D000908", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.377.715.548.114.179" } } }, { "@type": "MedicalWebPage", "name": "Anticorps antihelminthe", "alternateName": "Antibodies, Helminth", "url": "https://questionsmedicales.fr/mesh/D000909", "about": { "@type": "MedicalCondition", "name": "Anticorps antihelminthe", "code": { "@type": "MedicalCode", "code": "D000909", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.377.715.548.114.185" } } }, { "@type": "MedicalWebPage", "name": "Anticorps hétérophiles", "alternateName": "Antibodies, Heterophile", "url": "https://questionsmedicales.fr/mesh/D000910", "about": { "@type": "MedicalCondition", "name": "Anticorps hétérophiles", "code": { "@type": "MedicalCode", "code": "D000910", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.377.715.548.114.191" } } }, { "@type": "MedicalWebPage", "name": "Anticorps monoclonaux", "alternateName": "Antibodies, Monoclonal", "url": "https://questionsmedicales.fr/mesh/D000911", "about": { "@type": "MedicalCondition", "name": "Anticorps monoclonaux", "code": { "@type": "MedicalCode", "code": "D000911", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.377.715.548.114.224" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Anticorps monoclonaux humanisés", "alternateName": "Antibodies, Monoclonal, Humanized", "url": "https://questionsmedicales.fr/mesh/D061067", "about": { "@type": "MedicalCondition", "name": "Anticorps monoclonaux humanisés", "code": { "@type": "MedicalCode", "code": "D061067", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.377.715.548.114.224.200" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Adalimumab", "alternateName": "Adalimumab", "url": "https://questionsmedicales.fr/mesh/D000068879", "about": { "@type": "MedicalCondition", "name": "Adalimumab", "code": { "@type": "MedicalCode", "code": "D000068879", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.377.715.548.114.224.200.250" } } }, { "@type": "MedicalWebPage", "name": "Alemtuzumab", "alternateName": "Alemtuzumab", "url": "https://questionsmedicales.fr/mesh/D000074323", "about": { "@type": "MedicalCondition", "name": "Alemtuzumab", "code": { "@type": "MedicalCode", "code": "D000074323", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.377.715.548.114.224.200.375" } } }, { "@type": "MedicalWebPage", "name": "Basiliximab", "alternateName": "Basiliximab", "url": "https://questionsmedicales.fr/mesh/D000077552", "about": { "@type": "MedicalCondition", "name": "Basiliximab", "code": { "@type": "MedicalCode", "code": "D000077552", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.377.715.548.114.224.200.407" } } }, { "@type": "MedicalWebPage", "name": "Bévacizumab", "alternateName": "Bevacizumab", "url": "https://questionsmedicales.fr/mesh/D000068258", "about": { "@type": "MedicalCondition", "name": "Bévacizumab", "code": { "@type": "MedicalCode", "code": "D000068258", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.377.715.548.114.224.200.438" } } }, { "@type": "MedicalWebPage", "name": "Brentuximab védotine", "alternateName": "Brentuximab Vedotin", "url": "https://questionsmedicales.fr/mesh/D000079963", "about": { "@type": "MedicalCondition", "name": "Brentuximab védotine", "code": { "@type": "MedicalCode", "code": "D000079963", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.377.715.548.114.224.200.469" } } }, { "@type": "MedicalWebPage", "name": "Cétuximab", "alternateName": "Cetuximab", "url": "https://questionsmedicales.fr/mesh/D000068818", "about": { "@type": "MedicalCondition", "name": "Cétuximab", "code": { "@type": "MedicalCode", "code": "D000068818", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.377.715.548.114.224.200.750" } } }, { "@type": "MedicalWebPage", "name": "Daclizumab", "alternateName": "Daclizumab", "url": "https://questionsmedicales.fr/mesh/D000077561", "about": { "@type": "MedicalCondition", "name": "Daclizumab", "code": { "@type": "MedicalCode", "code": "D000077561", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.377.715.548.114.224.200.766" } } }, { "@type": "MedicalWebPage", "name": "Dénosumab", "alternateName": "Denosumab", "url": "https://questionsmedicales.fr/mesh/D000069448", "about": { "@type": "MedicalCondition", "name": "Dénosumab", "code": { "@type": "MedicalCode", "code": "D000069448", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.377.715.548.114.224.200.782" } } }, { "@type": "MedicalWebPage", "name": "Gemtuzumab", "alternateName": "Gemtuzumab", "url": "https://questionsmedicales.fr/mesh/D000079982", "about": { "@type": "MedicalCondition", "name": "Gemtuzumab", "code": { "@type": "MedicalCode", "code": "D000079982", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.377.715.548.114.224.200.790" } } }, { "@type": "MedicalWebPage", "name": "Inotuzumab ozogamicine", "alternateName": "Inotuzumab Ozogamicin", "url": "https://questionsmedicales.fr/mesh/D000080045", "about": { "@type": "MedicalCondition", "name": "Inotuzumab ozogamicine", "code": { "@type": "MedicalCode", "code": "D000080045", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.377.715.548.114.224.200.794" } } }, { "@type": "MedicalWebPage", "name": "Ipilimumab", "alternateName": "Ipilimumab", "url": "https://questionsmedicales.fr/mesh/D000074324", "about": { "@type": "MedicalCondition", "name": "Ipilimumab", "code": { "@type": "MedicalCode", "code": "D000074324", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.377.715.548.114.224.200.798" } } }, { "@type": "MedicalWebPage", "name": "Natalizumab", "alternateName": "Natalizumab", "url": "https://questionsmedicales.fr/mesh/D000069442", "about": { "@type": "MedicalCondition", "name": "Natalizumab", "code": { "@type": "MedicalCode", "code": "D000069442", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.377.715.548.114.224.200.813" } } }, { "@type": "MedicalWebPage", "name": "Nivolumab", "alternateName": "Nivolumab", "url": "https://questionsmedicales.fr/mesh/D000077594", "about": { "@type": "MedicalCondition", "name": "Nivolumab", "code": { "@type": "MedicalCode", "code": "D000077594", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.377.715.548.114.224.200.829" } } }, { "@type": "MedicalWebPage", "name": "Omalizumab", "alternateName": "Omalizumab", "url": "https://questionsmedicales.fr/mesh/D000069444", "about": { "@type": "MedicalCondition", "name": "Omalizumab", "code": { "@type": "MedicalCode", "code": "D000069444", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.377.715.548.114.224.200.844" } } }, { "@type": "MedicalWebPage", "name": "Palivizumab", "alternateName": "Palivizumab", "url": "https://questionsmedicales.fr/mesh/D000069455", "about": { "@type": "MedicalCondition", "name": "Palivizumab", "code": { "@type": "MedicalCode", "code": "D000069455", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.377.715.548.114.224.200.860" } } }, { "@type": "MedicalWebPage", "name": "Panitumumab", "alternateName": "Panitumumab", "url": "https://questionsmedicales.fr/mesh/D000077544", "about": { "@type": "MedicalCondition", "name": "Panitumumab", "code": { "@type": "MedicalCode", "code": "D000077544", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.377.715.548.114.224.200.864" } } }, { "@type": "MedicalWebPage", "name": "Ranibizumab", "alternateName": "Ranibizumab", "url": "https://questionsmedicales.fr/mesh/D000069579", "about": { "@type": "MedicalCondition", "name": "Ranibizumab", "code": { "@type": "MedicalCode", "code": "D000069579", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.377.715.548.114.224.200.868" } } }, { "@type": "MedicalWebPage", "name": "Trastuzumab", "alternateName": "Trastuzumab", "url": "https://questionsmedicales.fr/mesh/D000068878", "about": { "@type": "MedicalCondition", "name": "Trastuzumab", "code": { "@type": "MedicalCode", "code": "D000068878", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.377.715.548.114.224.200.875" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Ado-trastuzumab emtansine", "alternateName": "Ado-Trastuzumab Emtansine", "url": "https://questionsmedicales.fr/mesh/D000080044", "about": { "@type": "MedicalCondition", "name": "Ado-trastuzumab emtansine", "code": { "@type": "MedicalCode", "code": "D000080044", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.377.715.548.114.224.200.875.500" } } } ] }, { "@type": "MedicalWebPage", "name": "Ado-trastuzumab emtansine", "alternateName": "Ado-Trastuzumab Emtansine", "url": "https://questionsmedicales.fr/mesh/D000080044", "about": { "@type": "MedicalCondition", "name": "Ado-trastuzumab emtansine", "code": { "@type": "MedicalCode", "code": "D000080044", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.377.715.548.114.224.200.875.500" } } }, { "@type": "MedicalWebPage", "name": "Ustékinumab", "alternateName": "Ustekinumab", "url": "https://questionsmedicales.fr/mesh/D000069549", "about": { "@type": "MedicalCondition", "name": "Ustékinumab", "code": { "@type": "MedicalCode", "code": "D000069549", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.377.715.548.114.224.200.937" } } } ] }, { "@type": "MedicalWebPage", "name": "Adalimumab", "alternateName": "Adalimumab", "url": "https://questionsmedicales.fr/mesh/D000068879", "about": { "@type": "MedicalCondition", "name": "Adalimumab", "code": { "@type": "MedicalCode", "code": "D000068879", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.377.715.548.114.224.200.250" } } }, { "@type": "MedicalWebPage", "name": "Alemtuzumab", "alternateName": "Alemtuzumab", "url": "https://questionsmedicales.fr/mesh/D000074323", "about": { "@type": "MedicalCondition", "name": "Alemtuzumab", "code": { "@type": "MedicalCode", "code": "D000074323", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.377.715.548.114.224.200.375" } } }, { "@type": "MedicalWebPage", "name": "Basiliximab", "alternateName": "Basiliximab", "url": "https://questionsmedicales.fr/mesh/D000077552", "about": { "@type": "MedicalCondition", "name": "Basiliximab", "code": { "@type": "MedicalCode", "code": "D000077552", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.377.715.548.114.224.200.407" } } }, { "@type": "MedicalWebPage", "name": "Bévacizumab", "alternateName": "Bevacizumab", "url": "https://questionsmedicales.fr/mesh/D000068258", "about": { "@type": "MedicalCondition", "name": "Bévacizumab", "code": { "@type": "MedicalCode", "code": "D000068258", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.377.715.548.114.224.200.438" } } }, { "@type": "MedicalWebPage", "name": "Brentuximab védotine", "alternateName": "Brentuximab Vedotin", "url": "https://questionsmedicales.fr/mesh/D000079963", "about": { "@type": "MedicalCondition", "name": "Brentuximab védotine", "code": { "@type": "MedicalCode", "code": "D000079963", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.377.715.548.114.224.200.469" } } }, { "@type": "MedicalWebPage", "name": "Cétuximab", "alternateName": "Cetuximab", "url": "https://questionsmedicales.fr/mesh/D000068818", "about": { "@type": "MedicalCondition", "name": "Cétuximab", "code": { "@type": "MedicalCode", "code": "D000068818", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.377.715.548.114.224.200.750" } } }, { "@type": "MedicalWebPage", "name": "Daclizumab", "alternateName": "Daclizumab", "url": "https://questionsmedicales.fr/mesh/D000077561", "about": { "@type": "MedicalCondition", "name": "Daclizumab", "code": { "@type": "MedicalCode", "code": "D000077561", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.377.715.548.114.224.200.766" } } }, { "@type": "MedicalWebPage", "name": "Dénosumab", "alternateName": "Denosumab", "url": "https://questionsmedicales.fr/mesh/D000069448", "about": { "@type": "MedicalCondition", "name": "Dénosumab", "code": { "@type": "MedicalCode", "code": "D000069448", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.377.715.548.114.224.200.782" } } }, { "@type": "MedicalWebPage", "name": "Gemtuzumab", "alternateName": "Gemtuzumab", "url": "https://questionsmedicales.fr/mesh/D000079982", "about": { "@type": "MedicalCondition", "name": "Gemtuzumab", "code": { "@type": "MedicalCode", "code": "D000079982", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.377.715.548.114.224.200.790" } } }, { "@type": "MedicalWebPage", "name": "Inotuzumab ozogamicine", "alternateName": "Inotuzumab Ozogamicin", "url": "https://questionsmedicales.fr/mesh/D000080045", "about": { "@type": "MedicalCondition", "name": "Inotuzumab ozogamicine", "code": { "@type": "MedicalCode", "code": "D000080045", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.377.715.548.114.224.200.794" } } }, { "@type": "MedicalWebPage", "name": "Ipilimumab", "alternateName": "Ipilimumab", "url": "https://questionsmedicales.fr/mesh/D000074324", "about": { "@type": "MedicalCondition", "name": "Ipilimumab", "code": { "@type": "MedicalCode", "code": "D000074324", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.377.715.548.114.224.200.798" } } }, { "@type": "MedicalWebPage", "name": "Natalizumab", "alternateName": "Natalizumab", "url": "https://questionsmedicales.fr/mesh/D000069442", "about": { "@type": "MedicalCondition", "name": "Natalizumab", "code": { "@type": "MedicalCode", "code": "D000069442", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.377.715.548.114.224.200.813" } } }, { "@type": "MedicalWebPage", "name": "Nivolumab", "alternateName": "Nivolumab", "url": "https://questionsmedicales.fr/mesh/D000077594", "about": { "@type": "MedicalCondition", "name": "Nivolumab", "code": { "@type": "MedicalCode", "code": "D000077594", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.377.715.548.114.224.200.829" } } }, { "@type": "MedicalWebPage", "name": "Omalizumab", "alternateName": "Omalizumab", "url": "https://questionsmedicales.fr/mesh/D000069444", "about": { "@type": "MedicalCondition", "name": "Omalizumab", "code": { "@type": "MedicalCode", "code": "D000069444", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.377.715.548.114.224.200.844" } } }, { "@type": "MedicalWebPage", "name": "Palivizumab", "alternateName": "Palivizumab", "url": "https://questionsmedicales.fr/mesh/D000069455", "about": { "@type": "MedicalCondition", "name": "Palivizumab", "code": { "@type": "MedicalCode", "code": "D000069455", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.377.715.548.114.224.200.860" } } }, { "@type": "MedicalWebPage", "name": "Panitumumab", "alternateName": "Panitumumab", "url": "https://questionsmedicales.fr/mesh/D000077544", "about": { "@type": "MedicalCondition", "name": "Panitumumab", "code": { "@type": "MedicalCode", "code": "D000077544", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.377.715.548.114.224.200.864" } } }, { "@type": "MedicalWebPage", "name": "Ranibizumab", "alternateName": "Ranibizumab", "url": "https://questionsmedicales.fr/mesh/D000069579", "about": { "@type": "MedicalCondition", "name": "Ranibizumab", "code": { "@type": "MedicalCode", "code": "D000069579", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.377.715.548.114.224.200.868" } } }, { "@type": "MedicalWebPage", "name": "Trastuzumab", "alternateName": "Trastuzumab", "url": "https://questionsmedicales.fr/mesh/D000068878", "about": { "@type": "MedicalCondition", "name": "Trastuzumab", "code": { "@type": "MedicalCode", "code": "D000068878", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.377.715.548.114.224.200.875" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Ado-trastuzumab emtansine", "alternateName": "Ado-Trastuzumab Emtansine", "url": "https://questionsmedicales.fr/mesh/D000080044", "about": { "@type": "MedicalCondition", "name": "Ado-trastuzumab emtansine", "code": { "@type": "MedicalCode", "code": "D000080044", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.377.715.548.114.224.200.875.500" } } } ] }, { "@type": "MedicalWebPage", "name": "Ado-trastuzumab emtansine", "alternateName": "Ado-Trastuzumab Emtansine", "url": "https://questionsmedicales.fr/mesh/D000080044", "about": { "@type": "MedicalCondition", "name": "Ado-trastuzumab emtansine", "code": { "@type": "MedicalCode", "code": "D000080044", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.377.715.548.114.224.200.875.500" } } }, { "@type": "MedicalWebPage", "name": "Ustékinumab", "alternateName": "Ustekinumab", "url": "https://questionsmedicales.fr/mesh/D000069549", "about": { "@type": "MedicalCondition", "name": "Ustékinumab", "code": { "@type": "MedicalCode", "code": "D000069549", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.377.715.548.114.224.200.937" } } }, { "@type": "MedicalWebPage", "name": "Anticorps monoclonaux d'origine murine", "alternateName": "Antibodies, Monoclonal, Murine-Derived", "url": "https://questionsmedicales.fr/mesh/D058846", "about": { "@type": "MedicalCondition", "name": "Anticorps monoclonaux d'origine murine", "code": { "@type": "MedicalCode", "code": "D058846", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.377.715.548.114.224.284" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Rituximab", "alternateName": "Rituximab", "url": "https://questionsmedicales.fr/mesh/D000069283", "about": { "@type": "MedicalCondition", "name": "Rituximab", "code": { "@type": "MedicalCode", "code": "D000069283", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.377.715.548.114.224.284.785" } } } ] }, { "@type": "MedicalWebPage", "name": "Rituximab", "alternateName": "Rituximab", "url": "https://questionsmedicales.fr/mesh/D000069283", "about": { "@type": "MedicalCondition", "name": "Rituximab", "code": { "@type": "MedicalCode", "code": "D000069283", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.377.715.548.114.224.284.785" } } }, { "@type": "MedicalWebPage", "name": "Infliximab", "alternateName": "Infliximab", "url": "https://questionsmedicales.fr/mesh/D000069285", "about": { "@type": "MedicalCondition", "name": "Infliximab", "code": { "@type": "MedicalCode", "code": "D000069285", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.377.715.548.114.224.642" } } } ] }, { "@type": "MedicalWebPage", "name": "Anticorps antitumoraux", "alternateName": "Antibodies, Neoplasm", "url": "https://questionsmedicales.fr/mesh/D000912", "about": { "@type": "MedicalCondition", "name": "Anticorps antitumoraux", "code": { "@type": "MedicalCode", "code": "D000912", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.377.715.548.114.240" } } }, { "@type": "MedicalWebPage", "name": "Anticorps neutralisants", "alternateName": "Antibodies, Neutralizing", "url": "https://questionsmedicales.fr/mesh/D057134", "about": { "@type": "MedicalCondition", "name": "Anticorps neutralisants", "code": { "@type": "MedicalCode", "code": "D057134", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.377.715.548.114.244" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Anticorps neutralisants à large spectre", "alternateName": "Broadly Neutralizing Antibodies", "url": "https://questionsmedicales.fr/mesh/D000080908", "about": { "@type": "MedicalCondition", "name": "Anticorps neutralisants à large spectre", "code": { "@type": "MedicalCode", "code": "D000080908", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.377.715.548.114.244.500" } } } ] }, { "@type": "MedicalWebPage", "name": "Anticorps phospho-spécifiques", "alternateName": "Antibodies, Phospho-Specific", "url": "https://questionsmedicales.fr/mesh/D045163", "about": { "@type": "MedicalCondition", "name": "Anticorps phospho-spécifiques", "code": { "@type": "MedicalCode", "code": "D045163", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.377.715.548.114.248" } } }, { "@type": "MedicalWebPage", "name": "Anticorps antiprotozoaires", "alternateName": "Antibodies, Protozoan", "url": "https://questionsmedicales.fr/mesh/D000913", "about": { "@type": "MedicalCondition", "name": "Anticorps antiprotozoaires", "code": { "@type": "MedicalCode", "code": "D000913", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.377.715.548.114.252" } } }, { "@type": "MedicalWebPage", "name": "Anticorps antiviraux", "alternateName": "Antibodies, Viral", "url": "https://questionsmedicales.fr/mesh/D000914", "about": { "@type": "MedicalCondition", "name": "Anticorps antiviraux", "code": { "@type": "MedicalCode", "code": "D000914", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.377.715.548.114.254" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Anticorps antideltarétrovirus", "alternateName": "Deltaretrovirus Antibodies", "url": "https://questionsmedicales.fr/mesh/D015480", "about": { "@type": "MedicalCondition", "name": "Anticorps antideltarétrovirus", "code": { "@type": "MedicalCode", "code": "D015480", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.377.715.548.114.254.150" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Anticorps anti-VIH", "alternateName": "HIV Antibodies", "url": "https://questionsmedicales.fr/mesh/D015483", "about": { "@type": "MedicalCondition", "name": "Anticorps anti-VIH", "code": { "@type": "MedicalCode", "code": "D015483", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.377.715.548.114.254.150.440" } } }, { "@type": "MedicalWebPage", "name": "Anticorps anti-HTLVI", "alternateName": "HTLV-I Antibodies", "url": "https://questionsmedicales.fr/mesh/D015481", "about": { "@type": "MedicalCondition", "name": "Anticorps anti-HTLVI", "code": { "@type": "MedicalCode", "code": "D015481", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.377.715.548.114.254.150.500" } } }, { "@type": "MedicalWebPage", "name": "Anticorps anti-HTLVII", "alternateName": "HTLV-II Antibodies", "url": "https://questionsmedicales.fr/mesh/D015482", "about": { "@type": "MedicalCondition", "name": "Anticorps anti-HTLVII", "code": { "@type": "MedicalCode", "code": "D015482", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.377.715.548.114.254.150.510" } } } ] }, { "@type": "MedicalWebPage", "name": "Anticorps anti-VIH", "alternateName": "HIV Antibodies", "url": "https://questionsmedicales.fr/mesh/D015483", "about": { "@type": "MedicalCondition", "name": "Anticorps anti-VIH", "code": { "@type": "MedicalCode", "code": "D015483", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.377.715.548.114.254.150.440" } } }, { "@type": "MedicalWebPage", "name": "Anticorps anti-HTLVI", "alternateName": "HTLV-I Antibodies", "url": "https://questionsmedicales.fr/mesh/D015481", "about": { "@type": "MedicalCondition", "name": "Anticorps anti-HTLVI", "code": { "@type": "MedicalCode", "code": "D015481", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.377.715.548.114.254.150.500" } } }, { "@type": "MedicalWebPage", "name": "Anticorps anti-HTLVII", "alternateName": "HTLV-II Antibodies", "url": "https://questionsmedicales.fr/mesh/D015482", "about": { "@type": "MedicalCondition", "name": "Anticorps anti-HTLVII", "code": { "@type": "MedicalCode", "code": "D015482", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.377.715.548.114.254.150.510" } } }, { "@type": "MedicalWebPage", "name": "Anticorps de l'hépatite", "alternateName": "Hepatitis Antibodies", "url": "https://questionsmedicales.fr/mesh/D006508", "about": { "@type": "MedicalCondition", "name": "Anticorps de l'hépatite", "code": { "@type": "MedicalCode", "code": "D006508", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.377.715.548.114.254.450" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Anticorps de l'hépatite A", "alternateName": "Hepatitis A Antibodies", "url": "https://questionsmedicales.fr/mesh/D035922", "about": { "@type": "MedicalCondition", "name": "Anticorps de l'hépatite A", "code": { "@type": "MedicalCode", "code": "D035922", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.377.715.548.114.254.450.251" } } }, { "@type": "MedicalWebPage", "name": "Anticorps de l'hépatite B", "alternateName": "Hepatitis B Antibodies", "url": "https://questionsmedicales.fr/mesh/D006510", "about": { "@type": "MedicalCondition", "name": "Anticorps de l'hépatite B", "code": { "@type": "MedicalCode", "code": "D006510", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.377.715.548.114.254.450.504" } } }, { "@type": "MedicalWebPage", "name": "Anticorps de l'hépatite C", "alternateName": "Hepatitis C Antibodies", "url": "https://questionsmedicales.fr/mesh/D018937", "about": { "@type": "MedicalCondition", "name": "Anticorps de l'hépatite C", "code": { "@type": "MedicalCode", "code": "D018937", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.377.715.548.114.254.450.510" } } } ] }, { "@type": "MedicalWebPage", "name": "Anticorps de l'hépatite A", "alternateName": "Hepatitis A Antibodies", "url": "https://questionsmedicales.fr/mesh/D035922", "about": { "@type": "MedicalCondition", "name": "Anticorps de l'hépatite A", "code": { "@type": "MedicalCode", "code": "D035922", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.377.715.548.114.254.450.251" } } }, { "@type": "MedicalWebPage", "name": "Anticorps de l'hépatite B", "alternateName": "Hepatitis B Antibodies", "url": "https://questionsmedicales.fr/mesh/D006510", "about": { "@type": "MedicalCondition", "name": "Anticorps de l'hépatite B", "code": { "@type": "MedicalCode", "code": "D006510", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.377.715.548.114.254.450.504" } } }, { "@type": "MedicalWebPage", "name": "Anticorps de l'hépatite C", "alternateName": "Hepatitis C Antibodies", "url": "https://questionsmedicales.fr/mesh/D018937", "about": { "@type": "MedicalCondition", "name": "Anticorps de l'hépatite C", "code": { "@type": "MedicalCode", "code": "D018937", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.377.715.548.114.254.450.510" } } } ] }, { "@type": "MedicalWebPage", "name": "Autoanticorps", "alternateName": "Autoantibodies", "url": "https://questionsmedicales.fr/mesh/D001323", "about": { "@type": "MedicalCondition", "name": "Autoanticorps", "code": { "@type": "MedicalCode", "code": "D001323", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.377.715.548.114.323" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Anticorps anti-protéines citrullinées", "alternateName": "Anti-Citrullinated Protein Antibodies", "url": "https://questionsmedicales.fr/mesh/D000075422", "about": { "@type": "MedicalCondition", "name": "Anticorps anti-protéines citrullinées", "code": { "@type": "MedicalCode", "code": "D000075422", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.377.715.548.114.323.095" } } }, { "@type": "MedicalWebPage", "name": "Anticorps antinucléaires", "alternateName": "Antibodies, Antinuclear", "url": "https://questionsmedicales.fr/mesh/D000974", "about": { "@type": "MedicalCondition", "name": "Anticorps antinucléaires", "code": { "@type": "MedicalCode", "code": "D000974", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.377.715.548.114.323.204" } } }, { "@type": "MedicalWebPage", "name": "Anticorps antiphospholipides", "alternateName": "Antibodies, Antiphospholipid", "url": "https://questionsmedicales.fr/mesh/D017152", "about": { "@type": "MedicalCondition", "name": "Anticorps antiphospholipides", "code": { "@type": "MedicalCode", "code": "D017152", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.377.715.548.114.323.210" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Anticorps anticardiolipines", "alternateName": "Antibodies, Anticardiolipin", "url": "https://questionsmedicales.fr/mesh/D017153", "about": { "@type": "MedicalCondition", "name": "Anticorps anticardiolipines", "code": { "@type": "MedicalCode", "code": "D017153", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.377.715.548.114.323.210.100" } } } ] }, { "@type": "MedicalWebPage", "name": "Anticorps anticardiolipines", "alternateName": "Antibodies, Anticardiolipin", "url": "https://questionsmedicales.fr/mesh/D017153", "about": { "@type": "MedicalCondition", "name": "Anticorps anticardiolipines", "code": { "@type": "MedicalCode", "code": "D017153", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.377.715.548.114.323.210.100" } } }, { "@type": "MedicalWebPage", "name": "Facteur néphritique C3", "alternateName": "Complement C3 Nephritic Factor", "url": "https://questionsmedicales.fr/mesh/D003178", "about": { "@type": "MedicalCondition", "name": "Facteur néphritique C3", "code": { "@type": "MedicalCode", "code": "D003178", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.377.715.548.114.323.300" } } }, { "@type": "MedicalWebPage", "name": "Immunoconglutinines", "alternateName": "Immunoconglutinins", "url": "https://questionsmedicales.fr/mesh/D037561", "about": { "@type": "MedicalCondition", "name": "Immunoconglutinines", "code": { "@type": "MedicalCode", "code": "D037561", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.377.715.548.114.323.390" } } }, { "@type": "MedicalWebPage", "name": "Immunoglobulines thyréostimulantes", "alternateName": "Immunoglobulins, Thyroid-Stimulating", "url": "https://questionsmedicales.fr/mesh/D018828", "about": { "@type": "MedicalCondition", "name": "Immunoglobulines thyréostimulantes", "code": { "@type": "MedicalCode", "code": "D018828", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.377.715.548.114.323.480" } } }, { "@type": "MedicalWebPage", "name": "Facteur rhumatoïde", "alternateName": "Rheumatoid Factor", "url": "https://questionsmedicales.fr/mesh/D012217", "about": { "@type": "MedicalCondition", "name": "Facteur rhumatoïde", "code": { "@type": "MedicalCode", "code": "D012217", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.377.715.548.114.323.732" } } } ] }, { "@type": "MedicalWebPage", "name": "Abatacept", "alternateName": "Abatacept", "url": "https://questionsmedicales.fr/mesh/D000069594", "about": { "@type": "MedicalCondition", "name": "Abatacept", "code": { "@type": "MedicalCode", "code": "D000069594", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.377.715.548.114.580.225" } } }, { "@type": "MedicalWebPage", "name": "Isotypes des immunoglobulines", "alternateName": "Immunoglobulin Isotypes", "url": "https://questionsmedicales.fr/mesh/D007132", "about": { "@type": "MedicalCondition", "name": "Isotypes des immunoglobulines", "code": { "@type": "MedicalCode", "code": "D007132", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.377.715.548.114.619" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Immunoglobuline A", "alternateName": "Immunoglobulin A", "url": "https://questionsmedicales.fr/mesh/D007070", "about": { "@type": "MedicalCondition", "name": "Immunoglobuline A", "code": { "@type": "MedicalCode", "code": "D007070", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.377.715.548.114.619.026" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Immunoglobuline A sécrétoire", "alternateName": "Immunoglobulin A, Secretory", "url": "https://questionsmedicales.fr/mesh/D007071", "about": { "@type": "MedicalCondition", "name": "Immunoglobuline A sécrétoire", "code": { "@type": "MedicalCode", "code": "D007071", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.377.715.548.114.619.026.030" } } } ] }, { "@type": "MedicalWebPage", "name": "Immunoglobuline A sécrétoire", "alternateName": "Immunoglobulin A, Secretory", "url": "https://questionsmedicales.fr/mesh/D007071", "about": { "@type": "MedicalCondition", "name": "Immunoglobuline A sécrétoire", "code": { "@type": "MedicalCode", "code": "D007071", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.377.715.548.114.619.026.030" } } }, { "@type": "MedicalWebPage", "name": "Immunoglobuline D", "alternateName": "Immunoglobulin D", "url": "https://questionsmedicales.fr/mesh/D007072", "about": { "@type": "MedicalCondition", "name": "Immunoglobuline D", "code": { "@type": "MedicalCode", "code": "D007072", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.377.715.548.114.619.251" } } }, { "@type": "MedicalWebPage", "name": "Immunoglobuline E", "alternateName": "Immunoglobulin E", "url": "https://questionsmedicales.fr/mesh/D007073", "about": { "@type": "MedicalCondition", "name": "Immunoglobuline E", "code": { "@type": "MedicalCode", "code": "D007073", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.377.715.548.114.619.312" } } }, { "@type": "MedicalWebPage", "name": "Immunoglobuline G", "alternateName": "Immunoglobulin G", "url": "https://questionsmedicales.fr/mesh/D007074", "about": { "@type": "MedicalCondition", "name": "Immunoglobuline G", "code": { "@type": "MedicalCode", "code": "D007074", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.377.715.548.114.619.393" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "LATS", "alternateName": "Long-Acting Thyroid Stimulator", "url": "https://questionsmedicales.fr/mesh/D008135", "about": { "@type": "MedicalCondition", "name": "LATS", "code": { "@type": "MedicalCode", "code": "D008135", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.377.715.548.114.619.393.550" } } }, { "@type": "MedicalWebPage", "name": "Muromonab-CD3", "alternateName": "Muromonab-CD3", "url": "https://questionsmedicales.fr/mesh/D016853", "about": { "@type": "MedicalCondition", "name": "Muromonab-CD3", "code": { "@type": "MedicalCode", "code": "D016853", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.377.715.548.114.619.393.570" } } }, { "@type": "MedicalWebPage", "name": "Immunoglobuline Rh", "alternateName": "Rho(D) Immune Globulin", "url": "https://questionsmedicales.fr/mesh/D018029", "about": { "@type": "MedicalCondition", "name": "Immunoglobuline Rh", "code": { "@type": "MedicalCode", "code": "D018029", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.377.715.548.114.619.393.700" } } } ] }, { "@type": "MedicalWebPage", "name": "LATS", "alternateName": "Long-Acting Thyroid Stimulator", "url": "https://questionsmedicales.fr/mesh/D008135", "about": { "@type": "MedicalCondition", "name": "LATS", "code": { "@type": "MedicalCode", "code": "D008135", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.377.715.548.114.619.393.550" } } }, { "@type": "MedicalWebPage", "name": "Muromonab-CD3", "alternateName": "Muromonab-CD3", "url": "https://questionsmedicales.fr/mesh/D016853", "about": { "@type": "MedicalCondition", "name": "Muromonab-CD3", "code": { "@type": "MedicalCode", "code": "D016853", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.377.715.548.114.619.393.570" } } }, { "@type": "MedicalWebPage", "name": "Immunoglobuline Rh", "alternateName": "Rho(D) Immune Globulin", "url": "https://questionsmedicales.fr/mesh/D018029", "about": { "@type": "MedicalCondition", "name": "Immunoglobuline Rh", "code": { "@type": "MedicalCode", "code": "D018029", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.377.715.548.114.619.393.700" } } }, { "@type": "MedicalWebPage", "name": "Immunoglobuline M", "alternateName": "Immunoglobulin M", "url": "https://questionsmedicales.fr/mesh/D007075", "about": { "@type": "MedicalCondition", "name": "Immunoglobuline M", "code": { "@type": "MedicalCode", "code": "D007075", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.377.715.548.114.619.574" } } } ] }, { "@type": "MedicalWebPage", "name": "Immunoglobulines par voie veineuse", "alternateName": "Immunoglobulins, Intravenous", "url": "https://questionsmedicales.fr/mesh/D016756", "about": { "@type": "MedicalCondition", "name": "Immunoglobulines par voie veineuse", "code": { "@type": "MedicalCode", "code": "D016756", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.377.715.548.114.632" } } }, { "@type": "MedicalWebPage", "name": "Anticorps anti-insuline", "alternateName": "Insulin Antibodies", "url": "https://questionsmedicales.fr/mesh/D007330", "about": { "@type": "MedicalCondition", "name": "Anticorps anti-insuline", "code": { "@type": "MedicalCode", "code": "D007330", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.377.715.548.114.656" } } }, { "@type": "MedicalWebPage", "name": "Alloanticorps", "alternateName": "Isoantibodies", "url": "https://questionsmedicales.fr/mesh/D007518", "about": { "@type": "MedicalCondition", "name": "Alloanticorps", "code": { "@type": "MedicalCode", "code": "D007518", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.377.715.548.114.664" } } }, { "@type": "MedicalWebPage", "name": "Planticorps", "alternateName": "Plantibodies", "url": "https://questionsmedicales.fr/mesh/D046549", "about": { "@type": "MedicalCondition", "name": "Planticorps", "code": { "@type": "MedicalCode", "code": "D046549", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.377.715.548.114.820" } } }, { "@type": "MedicalWebPage", "name": "Précipitines", "alternateName": "Precipitins", "url": "https://questionsmedicales.fr/mesh/D011234", "about": { "@type": "MedicalCondition", "name": "Précipitines", "code": { "@type": "MedicalCode", "code": "D011234", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.377.715.548.114.837" } } }, { "@type": "MedicalWebPage", "name": "Réagines", "alternateName": "Reagins", "url": "https://questionsmedicales.fr/mesh/D011935", "about": { "@type": "MedicalCondition", "name": "Réagines", "code": { "@type": "MedicalCode", "code": "D011935", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.377.715.548.114.890" } } } ], "about": { "@type": "MedicalCondition", "name": "Anticorps", "alternateName": "Antibodies", "code": { "@type": "MedicalCode", "code": "D000906", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Anita Bandrowski", "url": "https://questionsmedicales.fr/author/Anita%20Bandrowski", "affiliation": { "@type": "Organization", "name": "Center for Research in Biological Systems, University of California , La Jolla, CA, USA." } }, { "@type": "Person", "name": "Sophana Chea", "url": "https://questionsmedicales.fr/author/Sophana%20Chea", "affiliation": { "@type": "Organization", "name": "International Center of Excellence in Research, National Institute of Allergy and Infectious Diseases, Phnom Penh, Cambodia." } }, { "@type": "Person", "name": "Laura Willen", "url": "https://questionsmedicales.fr/author/Laura%20Willen", "affiliation": { "@type": "Organization", "name": "Laboratory of Malaria and Vector Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, United States." } }, { "@type": "Person", "name": "Sreynik Nhek", "url": "https://questionsmedicales.fr/author/Sreynik%20Nhek", "affiliation": { "@type": "Organization", "name": "International Center of Excellence in Research, National Institute of Allergy and Infectious Diseases, Phnom Penh, Cambodia." } }, { "@type": "Person", "name": "Piseth Ly", "url": "https://questionsmedicales.fr/author/Piseth%20Ly", "affiliation": { "@type": "Organization", "name": "International Center of Excellence in Research, National Institute of Allergy and Infectious Diseases, Phnom Penh, Cambodia." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Refractive error in unilateral Duane syndrome.", "datePublished": "2022-09-16", "url": "https://questionsmedicales.fr/article/36122873", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.jaapos.2022.07.008" } }, { "@type": "ScholarlyArticle", "name": "Is refractive error a factor affecting scoliosis?", "datePublished": "2024-05-13", "url": "https://questionsmedicales.fr/article/38739623", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1371/journal.pone.0303324" } }, { "@type": "ScholarlyArticle", "name": "Peripheral optical anisotropy in refractive error groups.", "datePublished": "2023-02-07", "url": "https://questionsmedicales.fr/article/36751123", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1111/opo.13104" } }, { "@type": "ScholarlyArticle", "name": "Assessing the contribution of genetic nurture to refractive error.", "datePublished": "2022-05-27", "url": "https://questionsmedicales.fr/article/35618892", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1038/s41431-022-01126-6" } }, { "@type": "ScholarlyArticle", "name": "Myopia and Other Refractive Error and Their Relationships to Glaucoma Screening.", "datePublished": "2024-08-19", "url": "https://questionsmedicales.fr/article/39149950", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1097/IJG.0000000000002407" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Acides aminés, peptides et protéines", "item": "https://questionsmedicales.fr/mesh/D000602" }, { "@type": "ListItem", "position": 3, "name": "Protéines", "item": "https://questionsmedicales.fr/mesh/D011506" }, { "@type": "ListItem", "position": 4, "name": "Globulines", "item": "https://questionsmedicales.fr/mesh/D005916" }, { "@type": "ListItem", "position": 5, "name": "Sérum-globulines", "item": "https://questionsmedicales.fr/mesh/D012712" }, { "@type": "ListItem", "position": 6, "name": "Immunoglobulines", "item": "https://questionsmedicales.fr/mesh/D007136" }, { "@type": "ListItem", "position": 7, "name": "Anticorps", "item": "https://questionsmedicales.fr/mesh/D000906" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Anticorps - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Anticorps", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-13", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Anticorps", "description": "Comment détecte-t-on les anticorps dans le sang ?\nQuels tests sont utilisés pour les anticorps spécifiques ?\nLes anticorps peuvent-ils indiquer une infection ?\nQu'est-ce qu'un titre d'anticorps ?\nLes anticorps peuvent-ils être détectés chez les nouveau-nés ?", "url": "https://questionsmedicales.fr/mesh/D000906?mesh_terms=Refractive+Errors#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Anticorps", "description": "Quels symptômes indiquent une réponse immunitaire ?\nLes anticorps causent-ils des symptômes ?\nComment les anticorps affectent-ils les allergies ?\nLes anticorps peuvent-ils causer des maladies auto-immunes ?\nQuels anticorps sont liés aux infections virales ?", "url": "https://questionsmedicales.fr/mesh/D000906?mesh_terms=Refractive+Errors#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Anticorps", "description": "Comment les vaccins stimulent-ils la production d'anticorps ?\nLes anticorps peuvent-ils être transférés par le lait maternel ?\nComment maintenir un système immunitaire fort ?\nLes anticorps peuvent-ils être utilisés pour prévenir le COVID-19 ?\nLes anticorps sont-ils efficaces contre toutes les infections ?", "url": "https://questionsmedicales.fr/mesh/D000906?mesh_terms=Refractive+Errors#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Anticorps", "description": "Comment les anticorps sont-ils utilisés en thérapie ?\nLes anticorps peuvent-ils être administrés par injection ?\nQu'est-ce que l'immunothérapie par anticorps ?\nLes anticorps peuvent-ils être utilisés pour prévenir des maladies ?\nQuels sont les effets secondaires des traitements par anticorps ?", "url": "https://questionsmedicales.fr/mesh/D000906?mesh_terms=Refractive+Errors#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Anticorps", "description": "Quels sont les risques d'une surproduction d'anticorps ?\nLes anticorps peuvent-ils causer des réactions allergiques ?\nQuelles complications peuvent survenir avec des anticorps monoclonaux ?\nLes anticorps peuvent-ils interférer avec d'autres traitements ?\nQuelles sont les complications des maladies auto-immunes ?", "url": "https://questionsmedicales.fr/mesh/D000906?mesh_terms=Refractive+Errors#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Anticorps", "description": "Quels facteurs augmentent le risque de maladies auto-immunes ?\nLe stress influence-t-il la production d'anticorps ?\nL'âge influence-t-il la réponse des anticorps ?\nLes infections antérieures affectent-elles la production d'anticorps ?\nLes habitudes alimentaires influencent-elles les anticorps ?", "url": "https://questionsmedicales.fr/mesh/D000906?mesh_terms=Refractive+Errors#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment détecte-t-on les anticorps dans le sang ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "On utilise des tests sérologiques comme l'ELISA pour mesurer les anticorps." } }, { "@type": "Question", "name": "Quels tests sont utilisés pour les anticorps spécifiques ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Des tests comme l'immunofluorescence ou les tests d'agglutination sont utilisés." } }, { "@type": "Question", "name": "Les anticorps peuvent-ils indiquer une infection ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Oui, la présence d'anticorps spécifiques peut indiquer une infection antérieure." } }, { "@type": "Question", "name": "Qu'est-ce qu'un titre d'anticorps ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "C'est une mesure de la concentration d'anticorps dans le sang, indiquant l'immunité." } }, { "@type": "Question", "name": "Les anticorps peuvent-ils être détectés chez les nouveau-nés ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les anticorps maternels peuvent être détectés chez les nouveau-nés." } }, { "@type": "Question", "name": "Quels symptômes indiquent une réponse immunitaire ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Fièvre, fatigue, et inflammation peuvent indiquer une réponse immunitaire active." } }, { "@type": "Question", "name": "Les anticorps causent-ils des symptômes ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Non, ce sont les maladies ou infections que les anticorps combattent qui causent des symptômes." } }, { "@type": "Question", "name": "Comment les anticorps affectent-ils les allergies ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Les anticorps IgE sont impliqués dans les réactions allergiques, provoquant des symptômes." } }, { "@type": "Question", "name": "Les anticorps peuvent-ils causer des maladies auto-immunes ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des anticorps peuvent attaquer les tissus sains, entraînant des maladies auto-immunes." } }, { "@type": "Question", "name": "Quels anticorps sont liés aux infections virales ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Les anticorps IgM et IgG sont souvent associés aux infections virales." } }, { "@type": "Question", "name": "Comment les vaccins stimulent-ils la production d'anticorps ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Les vaccins introduisent des antigènes, entraînant la production d'anticorps spécifiques." } }, { "@type": "Question", "name": "Les anticorps peuvent-ils être transférés par le lait maternel ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les anticorps maternels sont transférés au bébé par le lait maternel, offrant une protection." } }, { "@type": "Question", "name": "Comment maintenir un système immunitaire fort ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Une alimentation équilibrée, l'exercice et le sommeil aident à maintenir un système immunitaire fort." } }, { "@type": "Question", "name": "Les anticorps peuvent-ils être utilisés pour prévenir le COVID-19 ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Des traitements par anticorps monoclonaux sont utilisés pour prévenir les formes graves du COVID-19." } }, { "@type": "Question", "name": "Les anticorps sont-ils efficaces contre toutes les infections ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Non, leur efficacité dépend du type d'infection et de la réponse immunitaire individuelle." } }, { "@type": "Question", "name": "Comment les anticorps sont-ils utilisés en thérapie ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Des anticorps monoclonaux sont utilisés pour traiter diverses maladies, y compris le cancer." } }, { "@type": "Question", "name": "Les anticorps peuvent-ils être administrés par injection ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les anticorps peuvent être administrés par injection pour traiter certaines maladies." } }, { "@type": "Question", "name": "Qu'est-ce que l'immunothérapie par anticorps ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "C'est un traitement qui utilise des anticorps pour renforcer la réponse immunitaire contre le cancer." } }, { "@type": "Question", "name": "Les anticorps peuvent-ils être utilisés pour prévenir des maladies ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des anticorps spécifiques peuvent être administrés pour prévenir certaines infections." } }, { "@type": "Question", "name": "Quels sont les effets secondaires des traitements par anticorps ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Les effets secondaires peuvent inclure des réactions allergiques et des infections." } }, { "@type": "Question", "name": "Quels sont les risques d'une surproduction d'anticorps ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Une surproduction peut entraîner des maladies auto-immunes ou des allergies graves." } }, { "@type": "Question", "name": "Les anticorps peuvent-ils causer des réactions allergiques ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Oui, certains anticorps peuvent provoquer des réactions allergiques en réponse à des allergènes." } }, { "@type": "Question", "name": "Quelles complications peuvent survenir avec des anticorps monoclonaux ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Des infections, des réactions allergiques et des effets secondaires peuvent survenir." } }, { "@type": "Question", "name": "Les anticorps peuvent-ils interférer avec d'autres traitements ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Oui, certains anticorps peuvent interagir avec d'autres médicaments, affectant leur efficacité." } }, { "@type": "Question", "name": "Quelles sont les complications des maladies auto-immunes ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Les complications incluent des dommages aux organes, des infections et une qualité de vie réduite." } }, { "@type": "Question", "name": "Quels facteurs augmentent le risque de maladies auto-immunes ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Des facteurs génétiques, environnementaux et hormonaux peuvent augmenter ce risque." } }, { "@type": "Question", "name": "Le stress influence-t-il la production d'anticorps ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le stress chronique peut affecter la réponse immunitaire et la production d'anticorps." } }, { "@type": "Question", "name": "L'âge influence-t-il la réponse des anticorps ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Oui, la réponse des anticorps peut diminuer avec l'âge, rendant les personnes âgées plus vulnérables." } }, { "@type": "Question", "name": "Les infections antérieures affectent-elles la production d'anticorps ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des infections antérieures peuvent influencer la mémoire immunitaire et la production d'anticorps." } }, { "@type": "Question", "name": "Les habitudes alimentaires influencent-elles les anticorps ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Oui, une alimentation riche en nutriments peut soutenir la production d'anticorps et la santé immunitaire." } } ] } ] }
Dr Olivier Menir

Contenu validé par Dr Olivier Menir

Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale


Validation scientifique effectuée le 25/04/2025

Contenu vérifié selon les dernières recommandations médicales

Sous-catégories

75 au total
└─

Anticorps anti-idiotypiques

Antibodies, Anti-Idiotypic D000888 - D12.776.377.715.548.114.071
└─

Anticorps anti-archéens

Antibodies, Archaeal D019844 - D12.776.377.715.548.114.107
└─

Anticorps antibactériens

Antibodies, Bacterial D000907 - D12.776.377.715.548.114.125
└─

Anticorps bispécifiques

Antibodies, Bispecific D018033 - D12.776.377.715.548.114.134
└─

Anticorps bloquants

Antibodies, Blocking D019138 - D12.776.377.715.548.114.143
└─

Anticorps catalytiques

Antibodies, Catalytic D017151 - D12.776.377.715.548.114.167
└─

Anticorps antifongiques

Antibodies, Fungal D000908 - D12.776.377.715.548.114.179
└─

Anticorps antihelminthe

Antibodies, Helminth D000909 - D12.776.377.715.548.114.185
└─

Anticorps hétérophiles

Antibodies, Heterophile D000910 - D12.776.377.715.548.114.191
└─

Anticorps monoclonaux

Antibodies, Monoclonal D000911 - D12.776.377.715.548.114.224
└─

Anticorps antitumoraux

Antibodies, Neoplasm D000912 - D12.776.377.715.548.114.240
└─

Anticorps neutralisants

Antibodies, Neutralizing D057134 - D12.776.377.715.548.114.244
└─

Anticorps phospho-spécifiques

Antibodies, Phospho-Specific D045163 - D12.776.377.715.548.114.248
└─

Anticorps antiprotozoaires

Antibodies, Protozoan D000913 - D12.776.377.715.548.114.252
└─

Anticorps antiviraux

Antibodies, Viral D000914 - D12.776.377.715.548.114.254
└─

Autoanticorps

Autoantibodies D001323 - D12.776.377.715.548.114.323
└─

Isotypes des immunoglobulines

Immunoglobulin Isotypes D007132 - D12.776.377.715.548.114.619
└─

Immunoglobulines par voie veineuse

Immunoglobulins, Intravenous D016756 - D12.776.377.715.548.114.632
└─

Anticorps anti-insuline

Insulin Antibodies D007330 - D12.776.377.715.548.114.656
└─

Alloanticorps

Isoantibodies D007518 - D12.776.377.715.548.114.664
└─

Planticorps

Plantibodies D046549 - D12.776.377.715.548.114.820
└─

Précipitines

Precipitins D011234 - D12.776.377.715.548.114.837
└─

Réagines

Reagins D011935 - D12.776.377.715.548.114.890
└─└─

Antistreptolysine

Antistreptolysin D000989 - D12.776.377.715.548.114.125.288
└─└─

Anticorps monoclonaux humanisés

Antibodies, Monoclonal, Humanized D061067 - D12.776.377.715.548.114.224.200
└─└─

Anticorps monoclonaux d'origine murine

Antibodies, Monoclonal, Murine-Derived D058846 - D12.776.377.715.548.114.224.284
└─└─

Infliximab

Infliximab D000069285 - D12.776.377.715.548.114.224.642
└─└─

Anticorps neutralisants à large spectre

Broadly Neutralizing Antibodies D000080908 - D12.776.377.715.548.114.244.500
└─└─

Anticorps antideltarétrovirus

Deltaretrovirus Antibodies D015480 - D12.776.377.715.548.114.254.150
└─└─

Anticorps de l'hépatite

Hepatitis Antibodies D006508 - D12.776.377.715.548.114.254.450
└─└─

Anticorps anti-protéines citrullinées

Anti-Citrullinated Protein Antibodies D000075422 - D12.776.377.715.548.114.323.095
└─└─

Anticorps antinucléaires

Antibodies, Antinuclear D000974 - D12.776.377.715.548.114.323.204
└─└─

Anticorps antiphospholipides

Antibodies, Antiphospholipid D017152 - D12.776.377.715.548.114.323.210
└─└─

Facteur néphritique C3

Complement C3 Nephritic Factor D003178 - D12.776.377.715.548.114.323.300
└─└─

Immunoconglutinines

Immunoconglutinins D037561 - D12.776.377.715.548.114.323.390
└─└─

Immunoglobulines thyréostimulantes

Immunoglobulins, Thyroid-Stimulating D018828 - D12.776.377.715.548.114.323.480
└─└─

Facteur rhumatoïde

Rheumatoid Factor D012217 - D12.776.377.715.548.114.323.732
└─└─

Abatacept

Abatacept D000069594 - D12.776.377.715.548.114.580.225
└─└─

Immunoglobuline A

Immunoglobulin A D007070 - D12.776.377.715.548.114.619.026
└─└─

Immunoglobuline D

Immunoglobulin D D007072 - D12.776.377.715.548.114.619.251
└─└─

Immunoglobuline E

Immunoglobulin E D007073 - D12.776.377.715.548.114.619.312
└─└─

Immunoglobuline G

Immunoglobulin G D007074 - D12.776.377.715.548.114.619.393
└─└─

Immunoglobuline M

Immunoglobulin M D007075 - D12.776.377.715.548.114.619.574
└─└─└─

Adalimumab

Adalimumab D000068879 - D12.776.377.715.548.114.224.200.250
└─└─└─

Alemtuzumab

Alemtuzumab D000074323 - D12.776.377.715.548.114.224.200.375
└─└─└─

Basiliximab

Basiliximab D000077552 - D12.776.377.715.548.114.224.200.407
└─└─└─

Bévacizumab

Bevacizumab D000068258 - D12.776.377.715.548.114.224.200.438
└─└─└─

Brentuximab védotine

Brentuximab Vedotin D000079963 - D12.776.377.715.548.114.224.200.469
└─└─└─

Cétuximab

Cetuximab D000068818 - D12.776.377.715.548.114.224.200.750
└─└─└─

Daclizumab

Daclizumab D000077561 - D12.776.377.715.548.114.224.200.766
└─└─└─

Dénosumab

Denosumab D000069448 - D12.776.377.715.548.114.224.200.782
└─└─└─

Gemtuzumab

Gemtuzumab D000079982 - D12.776.377.715.548.114.224.200.790
└─└─└─

Inotuzumab ozogamicine

Inotuzumab Ozogamicin D000080045 - D12.776.377.715.548.114.224.200.794
└─└─└─

Ipilimumab

Ipilimumab D000074324 - D12.776.377.715.548.114.224.200.798
└─└─└─

Natalizumab

Natalizumab D000069442 - D12.776.377.715.548.114.224.200.813
└─└─└─

Nivolumab

Nivolumab D000077594 - D12.776.377.715.548.114.224.200.829
└─└─└─

Omalizumab

Omalizumab D000069444 - D12.776.377.715.548.114.224.200.844
└─└─└─

Palivizumab

Palivizumab D000069455 - D12.776.377.715.548.114.224.200.860
└─└─└─

Panitumumab

Panitumumab D000077544 - D12.776.377.715.548.114.224.200.864
└─└─└─

Ranibizumab

Ranibizumab D000069579 - D12.776.377.715.548.114.224.200.868
└─└─└─

Trastuzumab

Trastuzumab D000068878 - D12.776.377.715.548.114.224.200.875
└─└─└─

Ustékinumab

Ustekinumab D000069549 - D12.776.377.715.548.114.224.200.937
└─└─└─

Rituximab

Rituximab D000069283 - D12.776.377.715.548.114.224.284.785
└─└─└─

Anticorps anti-VIH

HIV Antibodies D015483 - D12.776.377.715.548.114.254.150.440
└─└─└─

Anticorps anti-HTLVI

HTLV-I Antibodies D015481 - D12.776.377.715.548.114.254.150.500
└─└─└─

Anticorps anti-HTLVII

HTLV-II Antibodies D015482 - D12.776.377.715.548.114.254.150.510
└─└─└─

Anticorps de l'hépatite A

Hepatitis A Antibodies D035922 - D12.776.377.715.548.114.254.450.251
└─└─└─

Anticorps de l'hépatite B

Hepatitis B Antibodies D006510 - D12.776.377.715.548.114.254.450.504
└─└─└─

Anticorps de l'hépatite C

Hepatitis C Antibodies D018937 - D12.776.377.715.548.114.254.450.510
└─└─└─

Anticorps anticardiolipines

Antibodies, Anticardiolipin D017153 - D12.776.377.715.548.114.323.210.100
└─└─└─

Immunoglobuline A sécrétoire

Immunoglobulin A, Secretory D007071 - D12.776.377.715.548.114.619.026.030
└─└─└─

LATS

Long-Acting Thyroid Stimulator D008135 - D12.776.377.715.548.114.619.393.550
└─└─└─

Muromonab-CD3

Muromonab-CD3 D016853 - D12.776.377.715.548.114.619.393.570
└─└─└─

Immunoglobuline Rh

Rho(D) Immune Globulin D018029 - D12.776.377.715.548.114.619.393.700
└─└─└─└─

Ado-trastuzumab emtansine

Ado-Trastuzumab Emtansine D000080044 - D12.776.377.715.548.114.224.200.875.500

Auteurs principaux

Anita Bandrowski

3 publications dans cette catégorie

Affiliations :
  • Center for Research in Biological Systems, University of California , La Jolla, CA, USA.

Sophana Chea

2 publications dans cette catégorie

Affiliations :
  • International Center of Excellence in Research, National Institute of Allergy and Infectious Diseases, Phnom Penh, Cambodia.
Publications dans "Anticorps" :

Laura Willen

2 publications dans cette catégorie

Affiliations :
  • Laboratory of Malaria and Vector Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, United States.
Publications dans "Anticorps" :

Sreynik Nhek

2 publications dans cette catégorie

Affiliations :
  • International Center of Excellence in Research, National Institute of Allergy and Infectious Diseases, Phnom Penh, Cambodia.
Publications dans "Anticorps" :

Piseth Ly

2 publications dans cette catégorie

Affiliations :
  • International Center of Excellence in Research, National Institute of Allergy and Infectious Diseases, Phnom Penh, Cambodia.
Publications dans "Anticorps" :

Kristina Tang

2 publications dans cette catégorie

Affiliations :
  • Laboratory of Malaria and Vector Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, United States.
Publications dans "Anticorps" :

James Oristian

2 publications dans cette catégorie

Affiliations :
  • Laboratory of Malaria and Vector Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, United States.
Publications dans "Anticorps" :

Roberto Salas-Carrillo

2 publications dans cette catégorie

Affiliations :
  • Laboratory of Malaria and Vector Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, United States.
Publications dans "Anticorps" :

Aiyana Ponce

2 publications dans cette catégorie

Affiliations :
  • Laboratory of Malaria and Vector Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, United States.
Publications dans "Anticorps" :

Paola Carolina Valenzuela Leon

2 publications dans cette catégorie

Affiliations :
  • Laboratory of Malaria and Vector Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, United States.
Publications dans "Anticorps" :

Dara Kong

2 publications dans cette catégorie

Affiliations :
  • International Center of Excellence in Research, National Institute of Allergy and Infectious Diseases, Phnom Penh, Cambodia.
Publications dans "Anticorps" :

Sokna Ly

2 publications dans cette catégorie

Affiliations :
  • Laboratory of Malaria and Vector Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, United States.
Publications dans "Anticorps" :

Ratanak Sath

2 publications dans cette catégorie

Affiliations :
  • Laboratory of Malaria and Vector Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, United States.
Publications dans "Anticorps" :

Chanthap Lon

2 publications dans cette catégorie

Affiliations :
  • International Center of Excellence in Research, National Institute of Allergy and Infectious Diseases, Phnom Penh, Cambodia.
  • Laboratory of Malaria and Vector Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, United States.
Publications dans "Anticorps" :

Rithea Leang

2 publications dans cette catégorie

Affiliations :
  • National Center for Parasitology, Entomology, and Malaria Control, Ministry of Health, Phnom Penh, Cambodia.
  • National Dengue Control Program, Ministry of Health, Phnom Penh, Cambodia.
Publications dans "Anticorps" :

Rekol Huy

2 publications dans cette catégorie

Affiliations :
  • National Center for Parasitology, Entomology, and Malaria Control, Ministry of Health, Phnom Penh, Cambodia.
Publications dans "Anticorps" :

Christina Yek

2 publications dans cette catégorie

Affiliations :
  • International Center of Excellence in Research, National Institute of Allergy and Infectious Diseases, Phnom Penh, Cambodia.
  • Laboratory of Malaria and Vector Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, United States.
Publications dans "Anticorps" :

Jesus G Valenzuela

2 publications dans cette catégorie

Affiliations :
  • Laboratory of Malaria and Vector Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, United States.
Publications dans "Anticorps" :

Eric Calvo

2 publications dans cette catégorie

Affiliations :
  • Laboratory of Malaria and Vector Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, United States.
Publications dans "Anticorps" :

Jessica E Manning

2 publications dans cette catégorie

Affiliations :
  • International Center of Excellence in Research, National Institute of Allergy and Infectious Diseases, Phnom Penh, Cambodia.
  • Laboratory of Malaria and Vector Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, United States.
Publications dans "Anticorps" :

Sources (4303 au total)

Refractive error in unilateral Duane syndrome.

To investigate whether chronic co-contraction of the medial and lateral rectus muscles leads to higher against-the-rule astigmatism in affected versus fellow eyes in Duane syndrome.... A database of 4,103 patients of Dr. Arthur Jampolsky was queried for diagnosis of Duane syndrome. Inclusion criteria were unilateral Duane syndrome and complete data set. Refractive error was compared... A total of 84 patients with unilateral Duane syndrome were identified. The spherical equivalent of Duane eyes and fellow eyes was similar (0.4 vs. 0.2 [P = 0.14]). Mean cylinder power was higher in Du... Duane eyes compared to fellow eyes had higher astigmatism that was more likely to be oblique. Our study lends support to the hypothesis that extraocular muscles may influence refractive error....

Is refractive error a factor affecting scoliosis?

Scoliosis is one of the most common surgical disorders of the pediatric spine. Refractive errors are commonly associated with vision impairment worldwide. However, it is currently unclear whether refr... A cross-sectional study was performed in 2023, and a stratified cluster sampling technique was employed among school-aged students in Nantong City, China. Univariate and multivariate logistic regressi... The prevalence of scoliosis among school-aged students was 2.2% in Nantong city. Multiple logistic regression analyses showed that myopia, hyperopia, astigmatism, and anisometropia were not correlated... Refractive errors did not correlate with the development of scoliosis. However, BMI, living in rural areas and older age did correlate with the development of scoliosis....

Peripheral optical anisotropy in refractive error groups.

This study investigated differences in peripheral image quality with refractive error. Peripheral blur orientation is determined by the interaction of optical aberrations (such as oblique astigmatism)... Previously published Zernike coefficients across retinal eccentricity (0, 10, 20 and 30° horizontal nasal visual field) were used to compute the through-focus modulation transfer function (MTF) for a ... Across the horizontal nasal visual field (at 10, 20 and 30°), the peak image quality for emmetropes was within 0.3 D of the retina, as opposed to myopes whose best focus was behind the retina (-0.1, 0... Blur in the peripheral retina is dominated by the so-called "odd-error" blur signals, primarily due to oblique astigmatism. The orientation of peripheral blur (horizontal or vertical) provides the eye...

Myopia and Other Refractive Error and Their Relationships to Glaucoma Screening.

A large disk, a large parapapillary delta zone and a long axial length may be used as screening criteria to detect glaucomatous optic neuropathy in highly myopic eyes.... To describe aspects for screening of glaucomatous optic neuropathy in dependence of refractive error, under special consideration of high myopia.... Studies on the anatomy of the myopic optic nerve head and results of investigations on the relationship between glaucomatous optic neuropathy and axial myopia were included.... In the range from hyperopia to moderate myopia, refractive error is not a strong glaucoma risk factor and may not be included in glaucoma screening strategies. Care should be taken, that in moderate m...

Association between Refractive Errors and Ocular Biometry in an Elderly Population.

The anterior chamber depth in hyperopic eyes is significantly deeper than that in myopic eyes, and this finding is independent of the axial length.... This study aimed to determine the relationship between and refractive errors and ocular biometric components in a geriatric population 60 years and older.... The present population-based cross-sectional study was performed using a multistage random cluster sampling method in Tehran, Iran. After selecting the samples, visual acuity measurement, autorefracti... The correlation coefficients of spherical equivalent with axial length, corneal radius of curvature, axial length/corneal radius of curvature ratio, and anterior chamber depth were -0.40, 0.14, -0.63,... Among the biometric components, the axial length/corneal radius of curvature ratio has the strongest relationship with refractive errors. The anterior chamber depth is lower in myopes compared with hy...

The tolerance of refractive errors of extended depth of focus intraocular lens in patients with previous corneal refractive surgery.

To evaluate the tolerance for refractive errors and visual outcomes of extended depth of focus intraocular lens (EDOF IOLs) in patients with previous corneal refractive surgery for myopia.... Patients from Aier Eye Hospital of Wuhan University with previous myopia excimer laser correction underwent cataract surgery and implantation of an EDOF IOL. The follow-up period was three months. The... At the final visit, UDVA, CDVA, UIVA, and UNVA (LogMAR) were 0.06 ± 0.09, 0.01 ± 0.06, 0.11 ± 0.08, 0.20 ± 0.10, respectively. The mean spherical equivalent (SE) was - 0.57 ± 0.58D, sphere and cylinde... The EDOF IOL have a certain tolerance for refractive errors and corneal astigmatism, and it's recommended for patients with prior myopia excimer laser surgery to achieve satisfactory visual performanc...